Login
$CVS
$88.59 +$0.00 (0.0%) After hours

Company Executives

Management Team

From the 10-K annual report
Officer Age In this role 2025 pay Source
J. David Joyner Also a director
President and Chief Executive Officer and Chair of the Board of Directors
61 Not stated $21,214,084
Brian O. Newman
Executive Vice President and Chief Financial Officer
57 Since 2025
1 year
$9,420,508
Prem S. Shah
Executive Vice President and Group President
46 Since 2024
2 years
$13,379,210
Heidi B. Capozzi
Executive Vice President and Chief People Officer
56 Since 2024
2 years
Not reported
James D. Clark
SVP, Cont & Chief Acct Officer
Title from the Form 4 dated Jun 26, 2026
61 Not stated Not reported
Amy Compton-Philips
Executive Vice President and Chief Medical Officer
62 Since 2025
1 year
Not reported
Samrat S. Khichi
Executive Vice President, Chief Policy Officer and General Counsel
58 Since 2023
3 years
Not reported
Tilak Mandadi
EVP, Chief Exp & Tech Officer
Title from the Form 4 dated May 8, 2026
62 Not stated $10,977,716
Amy Compton-Phillips
EVP, Chief Medical Officer
Title from the Form 4 dated May 31, 2026
Not stated Not stated Not reported
Steven H. Nelson
Executive Vice President and President, Aetna
67 Since 2024
2 years
$11,587,110

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Apr 3, 2026 · updated by the 8-K of Aug 17, 2026

Directors
13
serving now
Independent
10 of 13
stated in the proxy
Average tenure
5.9 years
from year joined
CEO also chairs the board
Yes
J. David Joyner
Director Age On board Independent Committees Other public boards 2025 pay Source
J. David Joyner
61 2024
2 years
Not independent None stated None stated Paid as CEO
Michael F. Mahoney
61 2023
3 years
Independent None stated Boston Scientific Corporation $421,667
Fernando Aguirre
68 2018
8 years
Independent None stated Barry Callebaut AG, Synchrony Financial $365,000
Jeffrey R. Balser
64 2022
4 years
Independent None stated None stated Not stated
C. David Brown II
74 2007
19 years
Independent None stated None stated $360,000
Alecia A. DeCoudreaux
71 2015
11 years
Independent None stated Parnassus Funds/Parnassus Income Funds $335,000
Anne M. Finucane
73 2011
15 years
Independent None stated Williams-Sonoma, Inc. $347,500
John E. Gallina
66 2026
this year
Independent None stated Arrive AI Inc. Not stated
J. Scott Kirby
58 2023
3 years
Independent None stated United Airlines Holdings, Inc. $335,000
Leslie V. Norwalk
60 2024
2 years
Not independent None stated Arvinas, Inc., Neurocrine Biosciences, Inc., Globus Medical, Inc. $335,000
Guy P. Sansone
61 2024
2 years
Independent None stated Pediatrix Medical Group, Inc. $335,000
Douglas H. Shulman
58 2024
2 years
Independent None stated OneMain Holdings, Inc. $335,000
Roger N. Farah Leaving at the meeting
Not stated Not stated Not independent
Executive
None stated Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 3, 2026 states there were none.

Read it in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support